Bedaquiline-a potential inhibitor of COVID-19 main protease based on molecular docking. (2021). International Journal of Research in Pharmacology & Pharmacotherapeutics, 9(2), 136-144. https://doi.org/10.61096/ijrpp.v9.iss2.2020.136-144